Title: 3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
Official Title: 3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
Number of Sections: 1
Source: versions - Adopted Amendments
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
1 L.D. 784
2 Date: (Filing No. S- )
4 Reproduced and distributed under the direction of the Secretary of the Senate.
5 STATE OF MAINE
6 SENATE
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to S.P. 343, L.D. 784, “An Act to Require
10 Health Insurance Coverage for Specialized Risk Screening for First Responders”
11 Amend the bill by striking out the title and substituting the following:
12 'An Act to Create a Rebuttable Presumption Related to Specialized Risk Screening
13 for First Responders'
14 Amend the bill by striking out everything after the enacting clause and inserting the
15 following:
16 'Sec. 1. 24-A MRSA §4301-A, sub-§5-B is enacted to read:
17 5-B. First responder. "First responder" means an employee or occasional employee
18 of a state, county or municipal government entity or volunteer of a state, county or
19 municipal government entity that provides or has the authority to provide fire, emergency
20 medical, emergency communications, correctional or police services.
21 Sec. 2. 24-A MRSA §4301-A, sub-§19-A is enacted to read:
22 19-A. Specialized risk screening. "Specialized risk screening" means any of the
23 following standard, medically accepted tests:
24 A. Tests for evidence of any cancer with a known employment-related risk of exposure
25 for a first responder;
26 B. Blood tests, including tests conducted for a complete blood count, comprehensive
27 metabolic panel, renal panel and hepatic panel;
28 C. Mammography, colonoscopy or prostate examinations regardless of the age of the
29 person who is the subject of the examination;
30 D. Tests of any measure of serum activity of lipoprotein-associated phospholipase
31 enzyme A2, oxidized low-density lipoprotein or additional indicators of endovascular
32 inflammation; or
33 E. Tests to measure vitamin deficiencies, nutritional deficits and mineral levels.
Page 1 - 132LR0577(02)
COMMITTEE AMENDMENT
COMMITTEE AMENDMENT “ ” to S.P. 343, L.D. 784
1 Sec. 3. 24-A MRSA §4313, sub-§15 is enacted to read:
2 15. Rebuttable presumption. In a cause of action under this section or under Title
3 18-C, section 2-807 as permitted under subsection 14, there is a rebuttable presumption
4 that a carrier has failed to exercise ordinary care when making an adverse health care
5 treatment decision to deny coverage under a health plan for covered specialized risk
6 screening for an enrollee who is a first responder and whose provider has determined the
7 enrollee's receipt of specialized risk screening is medically appropriate and has meaningful
8 potential for preventive clinical benefit to the enrollee.
9 Sec. 4. Application. This Act applies to an adverse health care treatment decision
10 made by a carrier, as defined in the Maine Revised Statutes, Title 24-A, section 4301-A,
11 subsection 3, on or after the effective date of this Act.'
12 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
13 number to read consecutively.
14 SUMMARY
1155 This amendment, which is the majority report, changes the title and replaces the bill.
1166 The amendment establishes a rebuttable presumption in a cause of action that a health
1177 insurance carrier has failed to exercise ordinary care when making a health care treatment
1188 decision to deny coverage under a health plan for covered specialized risk screening for an
1199 enrollee who is a first responder and whose provider has determined the enrollee's receipt
2200 of specialized risk screening is medically appropriate and has meaningful potential for
2211 preventive clinical benefit to the enrollee. The amendment also clarifies that the rebuttable
2222 presumption applies if an enrollee files a wrongful death action instead of an action under
2233 the Maine Revised Statutes, Title 24-A, section 4313. The requirements of the amendment
2244 apply to health care treatment decisions made by a health insurance carrier on or after the
2255 effective date of this legislation.
2266 FISCAL NOTE REQUIRED
2277 (See attached)
Page 2 - 132LR0577(02)
COMMITTEE AMENDMENT
[DELETED: LD:(RC A “ t S 3 L 7 “ A t R0H1A2'3f4A5f6' 758o a s c o m g e o v o a s c o9m0m1 213f4A5f6B7m8C9p0D1e2i3E]
[DELETED:  11tt d t d c u a h p f c s rsepT0m1s2A3n5T6T7i8d9e0o1p2p3t4a5e6F7(]


================================================================================

Raw Text:
1 L.D. 784
2 Date: (Filing No. S- )
3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
4 Reproduced and distributed under the direction of the Secretary of the Senate.
5 STATE OF MAINE
6 SENATE
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to S.P. 343, L.D. 784, “An Act to Require
10 Health Insurance Coverage for Specialized Risk Screening for First Responders”
11 Amend the bill by striking out the title and substituting the following:
12 'An Act to Create a Rebuttable Presumption Related to Specialized Risk Screening
13 for First Responders'
14 Amend the bill by striking out everything after the enacting clause and inserting the
15 following:
16 'Sec. 1. 24-A MRSA §4301-A, sub-§5-B is enacted to read:
17 5-B. First responder. "First responder" means an employee or occasional employee
18 of a state, county or municipal government entity or volunteer of a state, county or
19 municipal government entity that provides or has the authority to provide fire, emergency
20 medical, emergency communications, correctional or police services.
21 Sec. 2. 24-A MRSA §4301-A, sub-§19-A is enacted to read:
22 19-A. Specialized risk screening. "Specialized risk screening" means any of the
23 following standard, medically accepted tests:
24 A. Tests for evidence of any cancer with a known employment-related risk of exposure
25 for a first responder;
26 B. Blood tests, including tests conducted for a complete blood count, comprehensive
27 metabolic panel, renal panel and hepatic panel;
28 C. Mammography, colonoscopy or prostate examinations regardless of the age of the
29 person who is the subject of the examination;
30 D. Tests of any measure of serum activity of lipoprotein-associated phospholipase
31 enzyme A2, oxidized low-density lipoprotein or additional indicators of endovascular
32 inflammation; or
33 E. Tests to measure vitamin deficiencies, nutritional deficits and mineral levels.
Page 1 - 132LR0577(02)
COMMITTEE AMENDMENT

COMMITTEE AMENDMENT “ ” to S.P. 343, L.D. 784
1 Sec. 3. 24-A MRSA §4313, sub-§15 is enacted to read:
2 15. Rebuttable presumption. In a cause of action under this section or under Title
3 18-C, section 2-807 as permitted under subsection 14, there is a rebuttable presumption
4 that a carrier has failed to exercise ordinary care when making an adverse health care
5 treatment decision to deny coverage under a health plan for covered specialized risk
6 screening for an enrollee who is a first responder and whose provider has determined the
7 enrollee's receipt of specialized risk screening is medically appropriate and has meaningful
8 potential for preventive clinical benefit to the enrollee.
9 Sec. 4. Application. This Act applies to an adverse health care treatment decision
10 made by a carrier, as defined in the Maine Revised Statutes, Title 24-A, section 4301-A,
11 subsection 3, on or after the effective date of this Act.'
12 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
13 number to read consecutively.
14 SUMMARY
1155 This amendment, which is the majority report, changes the title and replaces the bill.
1166 The amendment establishes a rebuttable presumption in a cause of action that a health
1177 insurance carrier has failed to exercise ordinary care when making a health care treatment
1188 decision to deny coverage under a health plan for covered specialized risk screening for an
1199 enrollee who is a first responder and whose provider has determined the enrollee's receipt
2200 of specialized risk screening is medically appropriate and has meaningful potential for
2211 preventive clinical benefit to the enrollee. The amendment also clarifies that the rebuttable
2222 presumption applies if an enrollee files a wrongful death action instead of an action under
2233 the Maine Revised Statutes, Title 24-A, section 4313. The requirements of the amendment
2244 apply to health care treatment decisions made by a health insurance carrier on or after the
2255 effective date of this legislation.
2266 FISCAL NOTE REQUIRED
2277 (See attached)
Page 2 - 132LR0577(02)
COMMITTEE AMENDMENT

[DELETED: LD:(RC A “ t S 3 L 7 “ A t R0H1A2'3f4A5f6' 758o a s c o m g e o v o a s c o9m0m1 213f4A5f6B7m8C9p0D1e2i3E]
[DELETED:  11tt d t d c u a h p f c s rsepT0m1s2A3n5T6T7i8d9e0o1p2p3t4a5e6F7(]